April 8, 2020 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, announced today that it has held a Type C meeting with the U.S. Food and Drug Administration (FDA) in which the data from the recently completed….
